Latest news
Xeris Biopharma Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 20:04:17 GMTTasrif Pharmaceutical granted second US patent for CD155-targeting antibody developed with Abzena's humanisation and immunogenicity platforms - Manufacturing ChemistManufacturing Chemist · Tue, 04 Aug 2026 12:14:55 GMTAdisyn Secures Second US Patent Allowance Covering Graphene-Coated Semiconductor Surfaces - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTAdisyn Secures Second US Patent For Graphene-Coated Products - SMBtechSMBtech · Fri, 31 Jul 2026 00:55:11 GMTTasrif secures second US patent for CD155-targeting antibodies as anti-TIGIT field contracts - AllSciAllSci · Wed, 29 Jul 2026 14:10:13 GMTTasrif Pharmaceutical Announces Grant of Second U.S. Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor (CD155) - finance.yahoo.comfinance.yahoo.com · Wed, 29 Jul 2026 07:00:00 GMTPilot Games Receives Notice of Allowance for Second U.S. Patent Protecting Electronic Pull-Tab Innovation - PR NewswirePR Newswire · Mon, 27 Jul 2026 07:00:00 GMT